JSP PHARMA · Dedicated research pages within JSP HOLDING

JSP PHARMA — Endometriosis research

Endometriosis has varied presentations and symptoms. The proposed therapeutic research programme must address disease biology, pain, fertility and quality of life.

Phenotypes and heterogeneity

Superficial, deep infiltrating and ovarian forms of endometriosis may present distinct medical and research challenges. We make no one-size-fits-all promise.

Modifying disease processes

We intend to investigate whether disease processes can be influenced selectively and safely rather than focusing exclusively on temporary symptom reduction.

Testability

Preclinical mechanisms, appropriate outcomes, risks to reproductive health and long-term follow-up are essential.

What this means for patients and collaborators

Each research step must be reviewed appropriately in advance and carefully documented. We do not offer treatment advice, diagnoses or sales claims based on a concept or an AI-generated hypothesis.

Current verifiable status

Endometriosis is a research objective following prioritisation of the leukaemia programme. No new medicine has been established as tested or approved.

Explore the research method → · Safety and regulatory requirements →